Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for SP1
Z-value: 4.20
Motif logo
Transcription factors associated with SP1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SP1
|
ENSG00000185591.5 | Sp1 transcription factor |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| SP1 | hg19_v2_chr12_+_53774423_53774658 | -0.13 | 4.8e-01 | Click! |
Activity profile of SP1 motif
Sorted Z-values of SP1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr6_+_43739697 | 9.50 |
ENST00000230480.6
|
VEGFA
|
vascular endothelial growth factor A |
| chr11_+_64073022 | 7.09 |
ENST00000406310.1
ENST00000000442.6 ENST00000539594.1 |
ESRRA
|
estrogen-related receptor alpha |
| chrX_+_109245863 | 6.63 |
ENST00000372072.3
|
TMEM164
|
transmembrane protein 164 |
| chr17_-_66453562 | 6.37 |
ENST00000262139.5
ENST00000546360.1 |
WIPI1
|
WD repeat domain, phosphoinositide interacting 1 |
| chr12_-_54982300 | 6.22 |
ENST00000547431.1
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
| chr19_+_50706866 | 6.04 |
ENST00000440075.2
ENST00000376970.2 ENST00000425460.1 ENST00000599920.1 ENST00000601313.1 |
MYH14
|
myosin, heavy chain 14, non-muscle |
| chr6_-_4135693 | 5.92 |
ENST00000495548.1
ENST00000380125.2 ENST00000465828.1 |
ECI2
|
enoyl-CoA delta isomerase 2 |
| chr20_+_33464368 | 5.74 |
ENST00000484354.1
ENST00000493805.2 ENST00000473172.1 |
ACSS2
|
acyl-CoA synthetase short-chain family member 2 |
| chr19_-_39226045 | 5.72 |
ENST00000597987.1
ENST00000595177.1 |
CAPN12
|
calpain 12 |
| chr20_+_33464407 | 5.68 |
ENST00000253382.5
|
ACSS2
|
acyl-CoA synthetase short-chain family member 2 |
| chr15_+_80445113 | 5.45 |
ENST00000407106.1
ENST00000261755.5 |
FAH
|
fumarylacetoacetate hydrolase (fumarylacetoacetase) |
| chr17_-_7155274 | 5.26 |
ENST00000318988.6
ENST00000575783.1 ENST00000573600.1 |
CTDNEP1
|
CTD nuclear envelope phosphatase 1 |
| chr1_-_38471156 | 5.23 |
ENST00000373016.3
|
FHL3
|
four and a half LIM domains 3 |
| chr3_-_48130314 | 5.15 |
ENST00000439356.1
ENST00000395734.3 ENST00000426837.2 |
MAP4
|
microtubule-associated protein 4 |
| chr20_-_3154162 | 5.03 |
ENST00000360342.3
|
LZTS3
|
Homo sapiens leucine zipper, putative tumor suppressor family member 3 (LZTS3), mRNA. |
| chr13_-_110438914 | 5.01 |
ENST00000375856.3
|
IRS2
|
insulin receptor substrate 2 |
| chr7_-_105925367 | 5.01 |
ENST00000354289.4
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
| chr12_+_110718921 | 4.94 |
ENST00000308664.6
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
| chr17_-_48943706 | 4.91 |
ENST00000499247.2
|
TOB1
|
transducer of ERBB2, 1 |
| chr6_-_4135825 | 4.91 |
ENST00000380118.3
ENST00000413766.2 ENST00000361538.2 |
ECI2
|
enoyl-CoA delta isomerase 2 |
| chrX_-_49041242 | 4.81 |
ENST00000453382.1
ENST00000540849.1 ENST00000536904.1 ENST00000432913.1 |
PRICKLE3
|
prickle homolog 3 (Drosophila) |
| chr2_+_27193480 | 4.80 |
ENST00000233121.2
ENST00000405074.3 |
MAPRE3
|
microtubule-associated protein, RP/EB family, member 3 |
| chr18_+_11981427 | 4.63 |
ENST00000269159.3
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr19_-_40971643 | 4.59 |
ENST00000595483.1
|
BLVRB
|
biliverdin reductase B (flavin reductase (NADPH)) |
| chr15_+_80445232 | 4.58 |
ENST00000561421.1
|
FAH
|
fumarylacetoacetate hydrolase (fumarylacetoacetase) |
| chr3_+_50654821 | 4.54 |
ENST00000457064.1
|
MAPKAPK3
|
mitogen-activated protein kinase-activated protein kinase 3 |
| chr5_-_114880533 | 4.54 |
ENST00000274457.3
|
FEM1C
|
fem-1 homolog c (C. elegans) |
| chr12_-_54982420 | 4.52 |
ENST00000257905.8
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
| chr18_+_11981014 | 4.47 |
ENST00000589238.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr20_+_33464238 | 4.46 |
ENST00000360596.2
|
ACSS2
|
acyl-CoA synthetase short-chain family member 2 |
| chr3_-_48130707 | 4.36 |
ENST00000360240.6
ENST00000383737.4 |
MAP4
|
microtubule-associated protein 4 |
| chr3_+_50649302 | 4.36 |
ENST00000446044.1
|
MAPKAPK3
|
mitogen-activated protein kinase-activated protein kinase 3 |
| chrX_+_43515467 | 4.35 |
ENST00000338702.3
ENST00000542639.1 |
MAOA
|
monoamine oxidase A |
| chr4_+_152330409 | 4.34 |
ENST00000513086.1
|
FAM160A1
|
family with sequence similarity 160, member A1 |
| chr19_-_2051223 | 4.28 |
ENST00000309340.7
ENST00000589534.1 ENST00000250896.3 ENST00000589509.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
| chr12_+_53400176 | 4.25 |
ENST00000551002.1
ENST00000420463.3 ENST00000416762.3 ENST00000549481.1 ENST00000552490.1 |
EIF4B
|
eukaryotic translation initiation factor 4B |
| chr1_+_10092890 | 4.24 |
ENST00000253251.8
ENST00000377157.3 |
UBE4B
|
ubiquitination factor E4B |
| chr7_+_65338312 | 4.22 |
ENST00000434382.2
|
VKORC1L1
|
vitamin K epoxide reductase complex, subunit 1-like 1 |
| chr6_+_3000218 | 4.21 |
ENST00000380441.1
ENST00000380455.4 ENST00000380454.4 |
NQO2
|
NAD(P)H dehydrogenase, quinone 2 |
| chr18_+_3449821 | 4.19 |
ENST00000407501.2
ENST00000405385.3 ENST00000546979.1 |
TGIF1
|
TGFB-induced factor homeobox 1 |
| chr16_+_29817399 | 4.16 |
ENST00000545521.1
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chr2_-_208634287 | 4.15 |
ENST00000295417.3
|
FZD5
|
frizzled family receptor 5 |
| chr13_-_76056250 | 4.15 |
ENST00000377636.3
ENST00000431480.2 ENST00000377625.2 ENST00000425511.1 |
TBC1D4
|
TBC1 domain family, member 4 |
| chr7_+_97910962 | 4.07 |
ENST00000539286.1
|
BRI3
|
brain protein I3 |
| chr18_+_11981547 | 4.07 |
ENST00000588927.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr11_-_130184555 | 4.07 |
ENST00000525842.1
|
ZBTB44
|
zinc finger and BTB domain containing 44 |
| chr6_+_44095347 | 4.06 |
ENST00000323267.6
|
TMEM63B
|
transmembrane protein 63B |
| chr19_-_2050852 | 4.01 |
ENST00000541165.1
ENST00000591601.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
| chr6_+_149638876 | 3.99 |
ENST00000392282.1
|
TAB2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
| chr19_-_40971667 | 3.95 |
ENST00000263368.4
|
BLVRB
|
biliverdin reductase B (flavin reductase (NADPH)) |
| chr7_-_51384451 | 3.95 |
ENST00000441453.1
ENST00000265136.7 ENST00000395542.2 ENST00000395540.2 |
COBL
|
cordon-bleu WH2 repeat protein |
| chr1_+_154975110 | 3.95 |
ENST00000535420.1
ENST00000368426.3 |
ZBTB7B
|
zinc finger and BTB domain containing 7B |
| chrX_+_135229559 | 3.93 |
ENST00000394155.2
|
FHL1
|
four and a half LIM domains 1 |
| chr14_-_21566731 | 3.93 |
ENST00000360947.3
|
ZNF219
|
zinc finger protein 219 |
| chr19_+_35532612 | 3.93 |
ENST00000600390.1
ENST00000597419.1 |
HPN
|
hepsin |
| chr12_+_121163602 | 3.90 |
ENST00000411593.2
|
ACADS
|
acyl-CoA dehydrogenase, C-2 to C-3 short chain |
| chr6_+_64282447 | 3.88 |
ENST00000370650.2
ENST00000578299.1 |
PTP4A1
|
protein tyrosine phosphatase type IVA, member 1 |
| chr9_-_35115836 | 3.88 |
ENST00000378566.1
ENST00000378554.2 ENST00000322813.5 |
FAM214B
|
family with sequence similarity 214, member B |
| chr19_-_11456935 | 3.88 |
ENST00000590788.1
ENST00000586590.1 ENST00000589555.1 ENST00000586956.1 ENST00000593256.2 ENST00000447337.1 ENST00000591677.1 ENST00000586701.1 ENST00000589655.1 |
TMEM205
RAB3D
|
transmembrane protein 205 RAB3D, member RAS oncogene family |
| chr6_-_34664612 | 3.86 |
ENST00000374023.3
ENST00000374026.3 |
C6orf106
|
chromosome 6 open reading frame 106 |
| chr3_-_113415441 | 3.85 |
ENST00000491165.1
ENST00000316407.4 |
KIAA2018
|
KIAA2018 |
| chr12_+_57522692 | 3.84 |
ENST00000554174.1
|
LRP1
|
low density lipoprotein receptor-related protein 1 |
| chr2_-_178129551 | 3.81 |
ENST00000430047.1
|
NFE2L2
|
nuclear factor, erythroid 2-like 2 |
| chr6_+_3000195 | 3.78 |
ENST00000338130.2
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2 |
| chr4_+_1003742 | 3.75 |
ENST00000398484.2
|
FGFRL1
|
fibroblast growth factor receptor-like 1 |
| chr19_-_46000251 | 3.74 |
ENST00000590526.1
ENST00000344680.4 ENST00000245923.4 |
RTN2
|
reticulon 2 |
| chr11_-_17410629 | 3.73 |
ENST00000526912.1
|
KCNJ11
|
potassium inwardly-rectifying channel, subfamily J, member 11 |
| chr1_-_9189229 | 3.72 |
ENST00000377411.4
|
GPR157
|
G protein-coupled receptor 157 |
| chr3_+_50654550 | 3.71 |
ENST00000430409.1
ENST00000357955.2 |
MAPKAPK3
|
mitogen-activated protein kinase-activated protein kinase 3 |
| chr17_+_55333876 | 3.71 |
ENST00000284073.2
|
MSI2
|
musashi RNA-binding protein 2 |
| chr12_-_58131931 | 3.70 |
ENST00000547588.1
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
| chr14_+_21945335 | 3.69 |
ENST00000262709.3
ENST00000457430.2 ENST00000448790.2 |
TOX4
|
TOX high mobility group box family member 4 |
| chr7_-_105925558 | 3.68 |
ENST00000222553.3
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
| chr2_+_44396000 | 3.68 |
ENST00000409895.4
ENST00000409432.3 ENST00000282412.4 ENST00000378551.2 ENST00000345249.4 |
PPM1B
|
protein phosphatase, Mg2+/Mn2+ dependent, 1B |
| chr9_-_126692386 | 3.67 |
ENST00000373624.2
ENST00000394219.3 ENST00000373620.3 ENST00000394215.2 ENST00000373618.1 |
DENND1A
|
DENN/MADD domain containing 1A |
| chr3_-_88108212 | 3.67 |
ENST00000482016.1
|
CGGBP1
|
CGG triplet repeat binding protein 1 |
| chr19_+_33166313 | 3.66 |
ENST00000334176.3
|
RGS9BP
|
regulator of G protein signaling 9 binding protein |
| chr1_+_10093188 | 3.65 |
ENST00000377153.1
|
UBE4B
|
ubiquitination factor E4B |
| chr6_-_44095183 | 3.65 |
ENST00000372014.3
|
MRPL14
|
mitochondrial ribosomal protein L14 |
| chr2_+_48541776 | 3.65 |
ENST00000413569.1
ENST00000340553.3 |
FOXN2
|
forkhead box N2 |
| chr10_-_104001231 | 3.64 |
ENST00000370002.3
|
PITX3
|
paired-like homeodomain 3 |
| chr6_+_44095263 | 3.63 |
ENST00000532634.1
|
TMEM63B
|
transmembrane protein 63B |
| chr2_-_240322685 | 3.62 |
ENST00000544989.1
|
HDAC4
|
histone deacetylase 4 |
| chr20_+_30407105 | 3.60 |
ENST00000375994.2
|
MYLK2
|
myosin light chain kinase 2 |
| chr12_-_42631529 | 3.59 |
ENST00000548917.1
|
YAF2
|
YY1 associated factor 2 |
| chr20_+_30407151 | 3.59 |
ENST00000375985.4
|
MYLK2
|
myosin light chain kinase 2 |
| chr10_+_11784360 | 3.56 |
ENST00000379215.4
ENST00000420401.1 |
ECHDC3
|
enoyl CoA hydratase domain containing 3 |
| chr17_-_7155775 | 3.54 |
ENST00000571409.1
|
CTDNEP1
|
CTD nuclear envelope phosphatase 1 |
| chr17_+_6926381 | 3.53 |
ENST00000576705.1
|
BCL6B
|
B-cell CLL/lymphoma 6, member B |
| chr12_+_100660909 | 3.53 |
ENST00000549687.1
|
SCYL2
|
SCY1-like 2 (S. cerevisiae) |
| chr11_+_66234216 | 3.52 |
ENST00000349459.6
ENST00000320740.7 ENST00000524466.1 ENST00000526296.1 |
PELI3
|
pellino E3 ubiquitin protein ligase family member 3 |
| chr16_+_5008290 | 3.52 |
ENST00000251170.7
|
SEC14L5
|
SEC14-like 5 (S. cerevisiae) |
| chr12_+_54694979 | 3.51 |
ENST00000552848.1
|
COPZ1
|
coatomer protein complex, subunit zeta 1 |
| chr12_+_100660940 | 3.50 |
ENST00000548392.1
|
SCYL2
|
SCY1-like 2 (S. cerevisiae) |
| chr12_+_53399942 | 3.49 |
ENST00000262056.9
|
EIF4B
|
eukaryotic translation initiation factor 4B |
| chr20_-_62130474 | 3.49 |
ENST00000217182.3
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
| chr7_+_36192855 | 3.48 |
ENST00000534978.1
|
EEPD1
|
endonuclease/exonuclease/phosphatase family domain containing 1 |
| chr19_+_6739662 | 3.48 |
ENST00000313285.8
ENST00000313244.9 ENST00000596758.1 |
TRIP10
|
thyroid hormone receptor interactor 10 |
| chrX_-_108976410 | 3.46 |
ENST00000504980.1
|
ACSL4
|
acyl-CoA synthetase long-chain family member 4 |
| chr10_+_120789223 | 3.44 |
ENST00000425699.1
|
NANOS1
|
nanos homolog 1 (Drosophila) |
| chrX_+_135229731 | 3.44 |
ENST00000420362.1
|
FHL1
|
four and a half LIM domains 1 |
| chr19_-_11456872 | 3.43 |
ENST00000586218.1
|
TMEM205
|
transmembrane protein 205 |
| chr6_+_43737939 | 3.42 |
ENST00000372067.3
|
VEGFA
|
vascular endothelial growth factor A |
| chr12_+_110719032 | 3.42 |
ENST00000395494.2
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
| chr17_+_4854375 | 3.42 |
ENST00000521811.1
ENST00000519602.1 ENST00000323997.6 ENST00000522249.1 ENST00000519584.1 |
ENO3
|
enolase 3 (beta, muscle) |
| chr7_-_129592700 | 3.41 |
ENST00000472396.1
ENST00000355621.3 |
UBE2H
|
ubiquitin-conjugating enzyme E2H |
| chr19_-_55791431 | 3.39 |
ENST00000593263.1
ENST00000376343.3 |
HSPBP1
|
HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1 |
| chr6_-_167040693 | 3.38 |
ENST00000366863.2
|
RPS6KA2
|
ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
| chr19_-_4065730 | 3.38 |
ENST00000601588.1
|
ZBTB7A
|
zinc finger and BTB domain containing 7A |
| chr19_+_50879705 | 3.37 |
ENST00000598168.1
ENST00000411902.2 ENST00000253727.5 ENST00000597790.1 ENST00000597130.1 ENST00000599105.1 |
NR1H2
|
nuclear receptor subfamily 1, group H, member 2 |
| chr3_+_49507559 | 3.37 |
ENST00000421560.1
ENST00000308775.2 ENST00000545947.1 ENST00000541308.1 ENST00000539901.1 ENST00000538711.1 ENST00000418588.1 |
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1) |
| chr19_-_42759266 | 3.36 |
ENST00000594664.1
|
AC006486.9
|
Uncharacterized protein |
| chr14_-_74551096 | 3.35 |
ENST00000350259.4
|
ALDH6A1
|
aldehyde dehydrogenase 6 family, member A1 |
| chr22_-_39548511 | 3.34 |
ENST00000434260.1
|
CBX7
|
chromobox homolog 7 |
| chr3_-_24536453 | 3.33 |
ENST00000453729.2
ENST00000413780.1 |
THRB
|
thyroid hormone receptor, beta |
| chrX_+_135229600 | 3.33 |
ENST00000370690.3
|
FHL1
|
four and a half LIM domains 1 |
| chr17_-_49198095 | 3.33 |
ENST00000505279.1
|
SPAG9
|
sperm associated antigen 9 |
| chr9_-_112260531 | 3.32 |
ENST00000374541.2
ENST00000262539.3 |
PTPN3
|
protein tyrosine phosphatase, non-receptor type 3 |
| chr22_+_38597889 | 3.31 |
ENST00000338483.2
ENST00000538320.1 ENST00000538999.1 ENST00000441709.1 |
MAFF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
| chr19_-_18392422 | 3.30 |
ENST00000252818.3
|
JUND
|
jun D proto-oncogene |
| chr7_+_97910981 | 3.29 |
ENST00000297290.3
|
BRI3
|
brain protein I3 |
| chr19_-_11456905 | 3.29 |
ENST00000588560.1
ENST00000592952.1 |
TMEM205
|
transmembrane protein 205 |
| chr14_+_105190514 | 3.29 |
ENST00000330877.2
|
ADSSL1
|
adenylosuccinate synthase like 1 |
| chr19_-_11457162 | 3.28 |
ENST00000590482.1
|
TMEM205
|
transmembrane protein 205 |
| chr12_+_57522439 | 3.27 |
ENST00000338962.4
|
LRP1
|
low density lipoprotein receptor-related protein 1 |
| chr2_-_220118631 | 3.27 |
ENST00000248437.4
|
TUBA4A
|
tubulin, alpha 4a |
| chr16_-_1993124 | 3.26 |
ENST00000473663.1
ENST00000399753.2 ENST00000564908.1 |
MSRB1
|
methionine sulfoxide reductase B1 |
| chr11_-_111783595 | 3.25 |
ENST00000528628.1
|
CRYAB
|
crystallin, alpha B |
| chr22_+_35695793 | 3.24 |
ENST00000456128.1
ENST00000449058.2 ENST00000411850.1 ENST00000425375.1 ENST00000436462.2 ENST00000382034.5 |
TOM1
|
target of myb1 (chicken) |
| chr4_+_152330390 | 3.23 |
ENST00000503146.1
ENST00000435205.1 |
FAM160A1
|
family with sequence similarity 160, member A1 |
| chrX_-_108976521 | 3.22 |
ENST00000469796.2
ENST00000502391.1 ENST00000508092.1 ENST00000340800.2 ENST00000348502.6 |
ACSL4
|
acyl-CoA synthetase long-chain family member 4 |
| chr19_-_17356697 | 3.22 |
ENST00000291442.3
|
NR2F6
|
nuclear receptor subfamily 2, group F, member 6 |
| chr5_+_148521454 | 3.20 |
ENST00000508983.1
|
ABLIM3
|
actin binding LIM protein family, member 3 |
| chr5_+_78985673 | 3.19 |
ENST00000446378.2
|
CMYA5
|
cardiomyopathy associated 5 |
| chr17_+_7348374 | 3.19 |
ENST00000306071.2
ENST00000572857.1 |
CHRNB1
|
cholinergic receptor, nicotinic, beta 1 (muscle) |
| chr4_-_185747188 | 3.18 |
ENST00000507295.1
ENST00000504900.1 ENST00000281455.2 ENST00000454703.2 |
ACSL1
|
acyl-CoA synthetase long-chain family member 1 |
| chr17_-_7155802 | 3.17 |
ENST00000572043.1
|
CTDNEP1
|
CTD nuclear envelope phosphatase 1 |
| chr19_+_47778119 | 3.17 |
ENST00000552360.2
|
PRR24
|
proline rich 24 |
| chr12_+_48513009 | 3.17 |
ENST00000359794.5
ENST00000551339.1 ENST00000395233.2 ENST00000548345.1 |
PFKM
|
phosphofructokinase, muscle |
| chr19_+_47760777 | 3.15 |
ENST00000599398.1
ENST00000595659.1 |
CCDC9
|
coiled-coil domain containing 9 |
| chrX_-_135056106 | 3.15 |
ENST00000433339.2
|
MMGT1
|
membrane magnesium transporter 1 |
| chr11_-_130184470 | 3.14 |
ENST00000357899.4
ENST00000397753.1 |
ZBTB44
|
zinc finger and BTB domain containing 44 |
| chr3_-_88108192 | 3.14 |
ENST00000309534.6
|
CGGBP1
|
CGG triplet repeat binding protein 1 |
| chr6_-_70506963 | 3.14 |
ENST00000370577.3
|
LMBRD1
|
LMBR1 domain containing 1 |
| chr19_+_17581253 | 3.14 |
ENST00000252595.7
ENST00000598424.1 |
SLC27A1
|
solute carrier family 27 (fatty acid transporter), member 1 |
| chr7_-_129592471 | 3.13 |
ENST00000473814.2
ENST00000490974.1 |
UBE2H
|
ubiquitin-conjugating enzyme E2H |
| chr3_+_9834227 | 3.13 |
ENST00000287613.7
ENST00000397261.3 |
ARPC4
|
actin related protein 2/3 complex, subunit 4, 20kDa |
| chr11_-_2906979 | 3.12 |
ENST00000380725.1
ENST00000313407.6 ENST00000430149.2 ENST00000440480.2 ENST00000414822.3 |
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
| chr7_+_128864848 | 3.11 |
ENST00000325006.3
ENST00000446544.2 |
AHCYL2
|
adenosylhomocysteinase-like 2 |
| chr19_+_56653064 | 3.10 |
ENST00000593100.1
|
ZNF444
|
zinc finger protein 444 |
| chr1_+_167905894 | 3.10 |
ENST00000367843.3
ENST00000432587.2 ENST00000312263.6 |
DCAF6
|
DDB1 and CUL4 associated factor 6 |
| chr16_-_75150665 | 3.10 |
ENST00000300051.4
ENST00000450168.2 |
LDHD
|
lactate dehydrogenase D |
| chr20_+_34894247 | 3.10 |
ENST00000373913.3
|
DLGAP4
|
discs, large (Drosophila) homolog-associated protein 4 |
| chr19_+_13056663 | 3.09 |
ENST00000541222.1
ENST00000316856.3 ENST00000586534.1 ENST00000592268.1 |
RAD23A
|
RAD23 homolog A (S. cerevisiae) |
| chr1_-_23751189 | 3.08 |
ENST00000374601.3
ENST00000450454.2 |
TCEA3
|
transcription elongation factor A (SII), 3 |
| chr19_-_56135928 | 3.08 |
ENST00000591479.1
ENST00000325351.4 |
ZNF784
|
zinc finger protein 784 |
| chr11_+_12696102 | 3.08 |
ENST00000527636.1
ENST00000527376.1 |
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
| chr19_+_8478154 | 3.06 |
ENST00000381035.4
ENST00000595142.1 ENST00000601724.1 ENST00000393944.1 ENST00000215555.2 ENST00000601283.1 ENST00000595213.1 |
MARCH2
|
membrane-associated ring finger (C3HC4) 2, E3 ubiquitin protein ligase |
| chr1_+_178994939 | 3.06 |
ENST00000440702.1
|
FAM20B
|
family with sequence similarity 20, member B |
| chr1_-_17445930 | 3.06 |
ENST00000375486.4
ENST00000375481.1 ENST00000444885.2 |
PADI2
|
peptidyl arginine deiminase, type II |
| chr16_+_56691838 | 3.06 |
ENST00000394501.2
|
MT1F
|
metallothionein 1F |
| chr4_-_129209221 | 3.05 |
ENST00000512483.1
|
PGRMC2
|
progesterone receptor membrane component 2 |
| chr1_+_211432775 | 3.04 |
ENST00000419091.2
|
RCOR3
|
REST corepressor 3 |
| chr1_-_53019059 | 3.03 |
ENST00000484723.2
ENST00000524582.1 |
ZCCHC11
|
zinc finger, CCHC domain containing 11 |
| chr5_+_148521381 | 3.02 |
ENST00000504238.1
|
ABLIM3
|
actin binding LIM protein family, member 3 |
| chr17_-_56591978 | 3.00 |
ENST00000583656.1
|
MTMR4
|
myotubularin related protein 4 |
| chr21_+_47743995 | 2.99 |
ENST00000359568.5
|
PCNT
|
pericentrin |
| chr2_+_5832799 | 2.99 |
ENST00000322002.3
|
SOX11
|
SRY (sex determining region Y)-box 11 |
| chr14_+_24600484 | 2.99 |
ENST00000267426.5
|
FITM1
|
fat storage-inducing transmembrane protein 1 |
| chr7_+_36192758 | 2.98 |
ENST00000242108.4
|
EEPD1
|
endonuclease/exonuclease/phosphatase family domain containing 1 |
| chrX_+_109246285 | 2.98 |
ENST00000372073.1
ENST00000372068.2 ENST00000288381.4 |
TMEM164
|
transmembrane protein 164 |
| chr7_-_105926058 | 2.97 |
ENST00000417537.1
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
| chr7_-_102257139 | 2.97 |
ENST00000521076.1
ENST00000462172.1 ENST00000522801.1 ENST00000449970.2 ENST00000262940.7 |
RASA4
|
RAS p21 protein activator 4 |
| chr10_-_103599591 | 2.96 |
ENST00000348850.5
|
KCNIP2
|
Kv channel interacting protein 2 |
| chr5_-_141257954 | 2.95 |
ENST00000456271.1
ENST00000394536.3 ENST00000503492.1 ENST00000287008.3 |
PCDH1
|
protocadherin 1 |
| chr6_+_108882069 | 2.95 |
ENST00000406360.1
|
FOXO3
|
forkhead box O3 |
| chr12_-_6715808 | 2.94 |
ENST00000545584.1
|
CHD4
|
chromodomain helicase DNA binding protein 4 |
| chr17_+_21188012 | 2.94 |
ENST00000529517.1
|
MAP2K3
|
mitogen-activated protein kinase kinase 3 |
| chr1_-_202936394 | 2.93 |
ENST00000367249.4
|
CYB5R1
|
cytochrome b5 reductase 1 |
| chr19_-_14201507 | 2.93 |
ENST00000533683.2
|
SAMD1
|
sterile alpha motif domain containing 1 |
| chr1_-_9189144 | 2.93 |
ENST00000414642.2
|
GPR157
|
G protein-coupled receptor 157 |
| chr6_-_160114260 | 2.92 |
ENST00000367054.2
ENST00000367055.4 ENST00000444946.2 ENST00000452684.2 |
SOD2
|
superoxide dismutase 2, mitochondrial |
| chr1_-_45140227 | 2.92 |
ENST00000372237.3
|
TMEM53
|
transmembrane protein 53 |
| chr7_+_73868220 | 2.92 |
ENST00000455841.2
|
GTF2IRD1
|
GTF2I repeat domain containing 1 |
| chr1_+_169075554 | 2.92 |
ENST00000367815.4
|
ATP1B1
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
| chr8_+_1711918 | 2.92 |
ENST00000331222.4
|
CLN8
|
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation) |
| chr20_+_48807351 | 2.91 |
ENST00000303004.3
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta |
| chr12_+_51158263 | 2.91 |
ENST00000539132.1
ENST00000552487.1 |
ATF1
|
activating transcription factor 1 |
| chr12_+_109592477 | 2.91 |
ENST00000544726.1
|
ACACB
|
acetyl-CoA carboxylase beta |
| chr14_-_21493649 | 2.91 |
ENST00000553442.1
ENST00000555869.1 ENST00000556457.1 ENST00000397844.2 ENST00000554415.1 |
NDRG2
|
NDRG family member 2 |
| chr3_-_50649192 | 2.91 |
ENST00000443053.2
ENST00000348721.3 |
CISH
|
cytokine inducible SH2-containing protein |
| chr19_-_14201776 | 2.90 |
ENST00000269724.5
|
SAMD1
|
sterile alpha motif domain containing 1 |
| chr17_+_7348658 | 2.90 |
ENST00000570557.1
ENST00000536404.2 ENST00000576360.1 |
CHRNB1
|
cholinergic receptor, nicotinic, beta 1 (muscle) |
| chr22_-_41940404 | 2.89 |
ENST00000355209.4
ENST00000337566.5 ENST00000396504.2 ENST00000407461.1 |
POLR3H
|
polymerase (RNA) III (DNA directed) polypeptide H (22.9kD) |
| chr3_+_135684515 | 2.89 |
ENST00000264977.3
ENST00000490467.1 |
PPP2R3A
|
protein phosphatase 2, regulatory subunit B'', alpha |
| chr6_-_160114293 | 2.87 |
ENST00000337404.4
ENST00000538183.2 |
SOD2
|
superoxide dismutase 2, mitochondrial |
| chr16_-_1993260 | 2.87 |
ENST00000361871.3
|
MSRB1
|
methionine sulfoxide reductase B1 |
| chr1_+_207226574 | 2.87 |
ENST00000367080.3
ENST00000367079.2 |
PFKFB2
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
| chr19_+_3359561 | 2.87 |
ENST00000589123.1
ENST00000346156.5 ENST00000395111.3 ENST00000586919.1 |
NFIC
|
nuclear factor I/C (CCAAT-binding transcription factor) |
| chr18_+_3449695 | 2.87 |
ENST00000343820.5
|
TGIF1
|
TGFB-induced factor homeobox 1 |
Network of associatons between targets according to the STRING database.
First level regulatory network of SP1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.9 | 14.6 | GO:1903570 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 3.6 | 10.8 | GO:1903515 | calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
| 2.7 | 16.2 | GO:0019541 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 2.2 | 6.7 | GO:0090108 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 2.0 | 8.1 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 2.0 | 5.9 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 1.9 | 15.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 1.9 | 9.4 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 1.9 | 7.5 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 1.8 | 5.5 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 1.7 | 1.7 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 1.7 | 7.0 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 1.7 | 8.5 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 1.6 | 4.9 | GO:0010160 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 1.6 | 7.9 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 1.6 | 7.9 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 1.5 | 7.7 | GO:1901094 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 1.5 | 4.6 | GO:2000656 | regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 1.5 | 7.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 1.5 | 4.5 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 1.5 | 4.4 | GO:0044209 | AMP salvage(GO:0044209) |
| 1.4 | 4.2 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
| 1.4 | 5.6 | GO:0090095 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 1.4 | 8.4 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 1.4 | 12.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 1.4 | 5.5 | GO:1903060 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
| 1.4 | 9.7 | GO:0051012 | microtubule sliding(GO:0051012) |
| 1.4 | 4.1 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
| 1.4 | 4.1 | GO:1990036 | positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) calcium ion import into sarcoplasmic reticulum(GO:1990036) |
| 1.3 | 4.0 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 1.3 | 4.0 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 1.3 | 10.5 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 1.3 | 5.2 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 1.3 | 6.5 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 1.3 | 3.8 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 1.3 | 13.8 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 1.2 | 1.2 | GO:0003169 | coronary vein morphogenesis(GO:0003169) |
| 1.2 | 3.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
| 1.2 | 4.9 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 1.2 | 2.5 | GO:1901383 | negative regulation of chorionic trophoblast cell proliferation(GO:1901383) |
| 1.2 | 8.5 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 1.2 | 10.6 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 1.2 | 11.7 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 1.2 | 9.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 1.2 | 1.2 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
| 1.2 | 6.9 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 1.2 | 2.3 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
| 1.1 | 8.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 1.1 | 6.9 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 1.1 | 4.6 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 1.1 | 4.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 1.1 | 10.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 1.1 | 5.7 | GO:1901536 | negative regulation of DNA demethylation(GO:1901536) |
| 1.1 | 1.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 1.1 | 2.2 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 1.1 | 2.2 | GO:0090316 | positive regulation of intracellular protein transport(GO:0090316) |
| 1.1 | 3.2 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 1.1 | 5.4 | GO:0008050 | female courtship behavior(GO:0008050) |
| 1.1 | 7.5 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 1.1 | 11.8 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 1.1 | 4.3 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 1.1 | 3.2 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 1.1 | 5.3 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 1.0 | 9.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 1.0 | 4.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 1.0 | 3.1 | GO:0018315 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 1.0 | 3.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 1.0 | 4.1 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 1.0 | 4.1 | GO:1903381 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 1.0 | 5.1 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 1.0 | 16.4 | GO:0044351 | macropinocytosis(GO:0044351) |
| 1.0 | 4.1 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 1.0 | 3.0 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 1.0 | 11.0 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 1.0 | 3.0 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 1.0 | 5.0 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 1.0 | 3.0 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 1.0 | 4.0 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 1.0 | 3.0 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 1.0 | 6.9 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
| 1.0 | 1.0 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 1.0 | 3.0 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 1.0 | 3.9 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
| 1.0 | 4.9 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 1.0 | 2.9 | GO:1901340 | negative regulation of store-operated calcium channel activity(GO:1901340) |
| 1.0 | 1.0 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
| 1.0 | 14.3 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.9 | 5.7 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.9 | 0.9 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.9 | 2.8 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.9 | 0.9 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
| 0.9 | 20.4 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.9 | 3.7 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.9 | 3.7 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
| 0.9 | 21.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.9 | 0.9 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.9 | 4.5 | GO:1900673 | olefin metabolic process(GO:1900673) |
| 0.9 | 4.5 | GO:0015862 | uridine transport(GO:0015862) |
| 0.9 | 0.9 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.9 | 3.5 | GO:0097069 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.9 | 0.9 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.9 | 1.7 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
| 0.9 | 3.5 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.9 | 12.2 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.9 | 11.3 | GO:0046449 | creatinine metabolic process(GO:0046449) |
| 0.9 | 7.8 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.9 | 3.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.9 | 4.3 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.9 | 2.6 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.9 | 5.1 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 0.9 | 10.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.8 | 5.9 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
| 0.8 | 4.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.8 | 2.5 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
| 0.8 | 0.8 | GO:0060157 | urinary bladder development(GO:0060157) |
| 0.8 | 2.5 | GO:0015880 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.8 | 6.7 | GO:0036018 | cellular response to erythropoietin(GO:0036018) |
| 0.8 | 1.7 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.8 | 2.5 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.8 | 6.5 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
| 0.8 | 4.0 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.8 | 7.3 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.8 | 3.2 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.8 | 2.4 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.8 | 2.4 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
| 0.8 | 4.0 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 0.8 | 0.8 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.8 | 2.4 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.8 | 0.8 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.8 | 0.8 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 0.8 | 7.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.8 | 3.2 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.8 | 0.8 | GO:0003197 | endocardial cushion development(GO:0003197) |
| 0.8 | 5.4 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 0.8 | 1.6 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.8 | 10.1 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
| 0.8 | 8.5 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.8 | 23.9 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.8 | 8.5 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.8 | 3.1 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.8 | 0.8 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 0.8 | 0.8 | GO:0014855 | striated muscle cell proliferation(GO:0014855) |
| 0.8 | 3.1 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.8 | 3.1 | GO:0005997 | xylulose metabolic process(GO:0005997) |
| 0.8 | 3.1 | GO:0035669 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.8 | 2.3 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
| 0.8 | 6.1 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.8 | 3.8 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.8 | 13.6 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.8 | 5.3 | GO:1901377 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.8 | 0.8 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.8 | 2.3 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.7 | 3.7 | GO:0052042 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
| 0.7 | 0.7 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
| 0.7 | 3.0 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.7 | 9.6 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.7 | 3.7 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.7 | 1.5 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.7 | 2.9 | GO:0033133 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
| 0.7 | 2.9 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.7 | 1.4 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
| 0.7 | 0.7 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) |
| 0.7 | 3.6 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.7 | 11.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.7 | 2.1 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.7 | 6.4 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.7 | 4.9 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.7 | 2.8 | GO:0072334 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.7 | 7.0 | GO:0071316 | cellular response to nicotine(GO:0071316) |
| 0.7 | 2.1 | GO:1903489 | epithelial cell differentiation involved in salivary gland development(GO:0060690) epithelial cell maturation involved in salivary gland development(GO:0060691) regulation of plasma cell differentiation(GO:1900098) positive regulation of plasma cell differentiation(GO:1900100) positive regulation of lactation(GO:1903489) |
| 0.7 | 1.4 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
| 0.7 | 2.1 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.7 | 0.7 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.7 | 4.2 | GO:0035900 | response to isolation stress(GO:0035900) |
| 0.7 | 6.3 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.7 | 2.1 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
| 0.7 | 2.8 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.7 | 0.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.7 | 5.5 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.7 | 6.2 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.7 | 3.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.7 | 0.7 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 0.7 | 2.1 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.7 | 2.0 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.7 | 2.7 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.7 | 5.4 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
| 0.7 | 8.8 | GO:0060613 | fat pad development(GO:0060613) |
| 0.7 | 2.7 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.7 | 0.7 | GO:1902309 | regulation of peptidyl-serine dephosphorylation(GO:1902308) negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.7 | 1.3 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
| 0.7 | 4.0 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.7 | 3.3 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.7 | 7.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.7 | 6.0 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.7 | 2.0 | GO:0090472 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 0.7 | 11.9 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.7 | 8.6 | GO:0030091 | protein repair(GO:0030091) |
| 0.7 | 4.0 | GO:0001757 | somite specification(GO:0001757) |
| 0.7 | 2.0 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 0.7 | 3.9 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
| 0.7 | 4.6 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.7 | 2.6 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.6 | 1.3 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.6 | 3.2 | GO:0021747 | cochlear nucleus development(GO:0021747) |
| 0.6 | 1.3 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.6 | 3.8 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.6 | 6.4 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
| 0.6 | 1.3 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.6 | 13.4 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.6 | 5.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.6 | 1.9 | GO:0060117 | auditory receptor cell development(GO:0060117) |
| 0.6 | 4.4 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.6 | 10.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.6 | 5.7 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 0.6 | 1.9 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.6 | 4.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.6 | 1.9 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.6 | 3.1 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.6 | 6.2 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.6 | 6.2 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 0.6 | 6.8 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.6 | 2.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.6 | 1.9 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.6 | 4.9 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
| 0.6 | 0.6 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
| 0.6 | 0.6 | GO:0015942 | formate metabolic process(GO:0015942) |
| 0.6 | 4.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.6 | 3.7 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
| 0.6 | 3.6 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
| 0.6 | 3.6 | GO:0070417 | cellular response to cold(GO:0070417) |
| 0.6 | 9.0 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.6 | 1.8 | GO:0021896 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 0.6 | 1.2 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.6 | 4.8 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.6 | 2.4 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
| 0.6 | 1.8 | GO:0007387 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.6 | 8.4 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 0.6 | 1.2 | GO:0014009 | glial cell proliferation(GO:0014009) |
| 0.6 | 1.2 | GO:1903308 | regulation of chromatin modification(GO:1903308) |
| 0.6 | 1.8 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 0.6 | 1.8 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.6 | 0.6 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle exocytosis(GO:2000302) |
| 0.6 | 3.6 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
| 0.6 | 1.8 | GO:1900081 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 0.6 | 1.8 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.6 | 3.5 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.6 | 4.7 | GO:0010266 | response to vitamin B1(GO:0010266) |
| 0.6 | 3.5 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.6 | 5.3 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) |
| 0.6 | 1.2 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.6 | 5.8 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.6 | 1.7 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.6 | 2.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.6 | 2.3 | GO:0042851 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.6 | 1.7 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.6 | 3.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.6 | 4.0 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 0.6 | 3.4 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.6 | 2.3 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.6 | 2.3 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.6 | 0.6 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 0.6 | 5.1 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.6 | 9.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.6 | 7.3 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.6 | 9.0 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.6 | 4.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.6 | 2.2 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 0.6 | 3.9 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
| 0.6 | 2.2 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.6 | 2.2 | GO:2000230 | response to metformin(GO:1901558) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 0.6 | 0.6 | GO:0060932 | His-Purkinje system cell differentiation(GO:0060932) |
| 0.6 | 14.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.6 | 0.6 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
| 0.6 | 5.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.5 | 5.5 | GO:1902363 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.5 | 3.8 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.5 | 2.7 | GO:0046898 | response to cycloheximide(GO:0046898) |
| 0.5 | 2.7 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.5 | 6.5 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.5 | 3.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 0.5 | 0.5 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
| 0.5 | 4.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.5 | 1.6 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.5 | 1.6 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.5 | 1.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.5 | 2.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.5 | 6.9 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.5 | 8.0 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.5 | 1.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.5 | 10.1 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.5 | 22.3 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.5 | 1.6 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.5 | 15.4 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.5 | 10.6 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.5 | 0.5 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
| 0.5 | 1.1 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
| 0.5 | 2.6 | GO:0010044 | response to aluminum ion(GO:0010044) |
| 0.5 | 1.0 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.5 | 0.5 | GO:0034059 | response to anoxia(GO:0034059) |
| 0.5 | 1.6 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.5 | 2.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.5 | 5.7 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.5 | 11.4 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.5 | 0.5 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) |
| 0.5 | 0.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.5 | 2.6 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.5 | 2.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.5 | 3.1 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.5 | 1.0 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.5 | 1.5 | GO:0003250 | cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
| 0.5 | 2.0 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.5 | 1.5 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.5 | 1.5 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.5 | 0.5 | GO:0070613 | regulation of protein processing(GO:0070613) regulation of protein maturation(GO:1903317) |
| 0.5 | 2.5 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 0.5 | 2.5 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.5 | 1.0 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.5 | 1.0 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.5 | 1.5 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.5 | 5.5 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.5 | 1.5 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
| 0.5 | 1.0 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.5 | 3.5 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.5 | 3.0 | GO:0071280 | cellular response to copper ion(GO:0071280) |
| 0.5 | 1.0 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) |
| 0.5 | 5.4 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
| 0.5 | 2.5 | GO:0010269 | response to selenium ion(GO:0010269) |
| 0.5 | 2.0 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.5 | 1.0 | GO:0030578 | PML body organization(GO:0030578) |
| 0.5 | 5.4 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.5 | 1.0 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
| 0.5 | 1.9 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.5 | 0.5 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 0.5 | 2.9 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.5 | 5.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.5 | 1.4 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.5 | 5.7 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.5 | 0.5 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
| 0.5 | 3.3 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.5 | 4.3 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.5 | 1.9 | GO:0051413 | response to cortisone(GO:0051413) |
| 0.5 | 1.4 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.5 | 3.8 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.5 | 6.6 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.5 | 0.9 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
| 0.5 | 1.9 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
| 0.5 | 0.9 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.5 | 2.8 | GO:2001153 | negative regulation of glycogen (starch) synthase activity(GO:2000466) regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.5 | 10.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.5 | 13.9 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.5 | 2.8 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.5 | 2.3 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.5 | 3.7 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.5 | 0.9 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
| 0.5 | 1.4 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.5 | 3.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.5 | 1.4 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.5 | 0.9 | GO:1904044 | response to aldosterone(GO:1904044) |
| 0.5 | 1.8 | GO:0050992 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.5 | 3.6 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.5 | 2.3 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.5 | 1.4 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.5 | 0.9 | GO:0003192 | mitral valve formation(GO:0003192) |
| 0.5 | 1.4 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
| 0.4 | 1.3 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.4 | 1.3 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
| 0.4 | 2.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.4 | 1.3 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.4 | 7.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.4 | 6.7 | GO:0010255 | hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
| 0.4 | 0.9 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.4 | 1.8 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.4 | 0.9 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
| 0.4 | 2.7 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.4 | 3.1 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
| 0.4 | 4.4 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.4 | 4.4 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 0.4 | 2.2 | GO:0003183 | mitral valve morphogenesis(GO:0003183) |
| 0.4 | 11.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.4 | 5.7 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.4 | 3.9 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.4 | 7.4 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.4 | 4.8 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.4 | 39.8 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.4 | 0.9 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.4 | 2.2 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.4 | 3.0 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
| 0.4 | 1.7 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.4 | 0.9 | GO:1902823 | negative regulation of late endosome to lysosome transport(GO:1902823) |
| 0.4 | 2.6 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.4 | 0.9 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.4 | 8.6 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.4 | 1.3 | GO:0002931 | response to ischemia(GO:0002931) |
| 0.4 | 5.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.4 | 1.3 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.4 | 2.2 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.4 | 2.6 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.4 | 2.6 | GO:0036309 | protein localization to M-band(GO:0036309) |
| 0.4 | 0.4 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
| 0.4 | 1.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.4 | 3.9 | GO:0033197 | response to vitamin E(GO:0033197) |
| 0.4 | 4.7 | GO:0000050 | urea cycle(GO:0000050) |
| 0.4 | 2.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.4 | 0.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.4 | 0.4 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.4 | 1.3 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.4 | 2.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.4 | 0.4 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.4 | 0.4 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.4 | 1.7 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.4 | 3.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.4 | 0.8 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
| 0.4 | 2.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.4 | 1.3 | GO:1904640 | response to methionine(GO:1904640) |
| 0.4 | 2.5 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.4 | 2.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.4 | 2.9 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.4 | 4.6 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.4 | 4.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.4 | 3.3 | GO:0019835 | cytolysis(GO:0019835) |
| 0.4 | 7.0 | GO:0015871 | choline transport(GO:0015871) |
| 0.4 | 1.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.4 | 1.6 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.4 | 3.7 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.4 | 4.9 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 0.4 | 2.1 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.4 | 0.8 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
| 0.4 | 2.0 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.4 | 4.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.4 | 2.5 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.4 | 0.8 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 0.4 | 10.2 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.4 | 2.0 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.4 | 2.0 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.4 | 6.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.4 | 2.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.4 | 0.8 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
| 0.4 | 0.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.4 | 4.5 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.4 | 0.4 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 0.4 | 0.4 | GO:0036017 | response to erythropoietin(GO:0036017) |
| 0.4 | 2.8 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.4 | 4.8 | GO:0007512 | adult heart development(GO:0007512) |
| 0.4 | 0.8 | GO:0071233 | cellular response to leucine(GO:0071233) |
| 0.4 | 9.6 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.4 | 1.6 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.4 | 1.2 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
| 0.4 | 2.8 | GO:0060356 | leucine import(GO:0060356) |
| 0.4 | 1.6 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
| 0.4 | 2.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.4 | 2.8 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.4 | 0.4 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
| 0.4 | 14.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.4 | 11.4 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.4 | 2.7 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.4 | 1.6 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.4 | 0.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.4 | 2.0 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.4 | 3.5 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.4 | 3.1 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.4 | 3.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.4 | 1.2 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.4 | 0.4 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.4 | 0.4 | GO:1901859 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.4 | 11.3 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.4 | 5.4 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.4 | 1.2 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.4 | 10.4 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.4 | 0.8 | GO:1903243 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.4 | 3.5 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.4 | 1.2 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
| 0.4 | 1.9 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 0.4 | 1.2 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.4 | 0.4 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
| 0.4 | 1.2 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.4 | 1.2 | GO:0018201 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) peptidyl-glycine modification(GO:0018201) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.4 | 3.5 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.4 | 3.1 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.4 | 3.8 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.4 | 1.1 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
| 0.4 | 1.9 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.4 | 1.9 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.4 | 1.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.4 | 1.9 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.4 | 1.5 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.4 | 6.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.4 | 1.9 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.4 | 4.5 | GO:0042407 | cristae formation(GO:0042407) |
| 0.4 | 0.4 | GO:0009750 | response to fructose(GO:0009750) |
| 0.4 | 2.2 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
| 0.4 | 0.7 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 0.4 | 1.1 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
| 0.4 | 6.0 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.4 | 3.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.4 | 1.1 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.4 | 1.8 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.4 | 5.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
| 0.4 | 1.1 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.4 | 0.4 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.4 | 1.1 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.4 | 0.4 | GO:0099545 | trans-synaptic signaling by trans-synaptic complex(GO:0099545) |
| 0.4 | 0.7 | GO:1901656 | glycoside transport(GO:1901656) |
| 0.4 | 3.7 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.4 | 2.9 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
| 0.4 | 1.1 | GO:0019471 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) |
| 0.4 | 4.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.4 | 4.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.4 | 0.7 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 0.4 | 6.2 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.4 | 2.9 | GO:0098706 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.4 | 4.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.4 | 1.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.4 | 0.4 | GO:0055001 | muscle cell development(GO:0055001) |
| 0.4 | 1.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 0.4 | 4.3 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.4 | 3.2 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
| 0.4 | 4.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.4 | 0.7 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.4 | 0.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.4 | 0.7 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.4 | 2.5 | GO:0030217 | T cell differentiation(GO:0030217) |
| 0.4 | 7.8 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.4 | 1.1 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.4 | 0.7 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.4 | 0.7 | GO:0070295 | renal water absorption(GO:0070295) |
| 0.4 | 0.4 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.4 | 2.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.4 | 3.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.4 | 2.8 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.4 | 0.7 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
| 0.4 | 1.4 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.4 | 1.4 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 0.4 | 2.8 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.4 | 13.0 | GO:0097503 | sialylation(GO:0097503) |
| 0.4 | 1.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.4 | 1.4 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.4 | 4.9 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
| 0.4 | 1.8 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.4 | 9.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.3 | 1.4 | GO:190226 |